EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts

Ton Schoenmaker iD, Joy Zwaak, Bruno G Loos, Richard Volckmann iD, Jan Koster iD, E Marelise W Eekhoff iD, Teun J de Vries iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ton Schoenmaker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, 1081 LA Amste…. Hauptthemen laut MEDLINE: Myositis Ossificans, Ossification, Heterotopic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Friends of Dutch FOP foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrodysplasia Ossificans Progressiva (FOP) is a very rare genetic disease characterized by progressive heterotopic ossification (HO) of soft tissues, leading to immobility and premature death. FOP is caused by a mutation in the Activin receptor Type 1 (ACVR1) gene, resulting in altered responsiveness to Activin-A. We recently revealed that Activin-A induces fewer, but larger and more active, osteoclasts regardless of the presence of the mutated ACVR1 receptor. The underlying mechanism of Activin-A-induced changes in osteoclastogenesis at the gene expression level remains unknown. Transcriptomic changes induced by Activin-A during osteoclast formation from healthy controls and patient-derived CD14-positive monocytes were studied using RNA sequencing. CD14-positive monocytes from six FOP patients and six age- and sex-matched healthy controls were differentiated into osteoclasts in the absence or presence of Activin-A. RNA samples were isolated after 14 days of culturing and analyzed by RNA sequencing. Non-supervised principal component analysis (PCA) showed that samples from the same culture conditions (e.g., without or with Activin-A) tended to cluster, indicating that the variability induced by Activin-A treatment was larger than the variability between the control and FOP samples. RNA sequencing analysis revealed 1480 differentially expressed genes induced by Activin-A in healthy control and FOP osteoclasts with p(adj) < 0.01 and a Log2 fold change of ≥±2. Pathway and gene ontology enrichment analysis revealed several significantly enriched pathways for genes upregulated by Activin-A that could be linked to the differentiation or function of osteoclasts, cell fusion or inflammation. Our data showed that Activin-A has a substantial effect on gene expression during osteoclast formation and that this effect occurred regardless of the presence of the mutated ACVR1 receptor causing FOP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myositis OssificansOssification, HeterotopicHumansOsteoclastsTranscriptomeActivinsMutationActivin Receptors, Type I

Stichwörter der Autor:innen

Activin-ARNAseqcell sizefibrodysplasia ossificans progressivaosteoclast

Substanzen

ActivinsActivin Receptors, Type I

Autor:innen und Institutionen

  • Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, 1081 LA Amsterdam, The Netherlands.
  • Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Department of Internal Medicine Section Endocrinology, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.
  • Rare Bone Disease Center Amsterdam, Bone Center, 1081 HV Amsterdam, The Netherlands.

ORCID-Profile: Ton Schoenmaker, Richard Volckmann, Jan Koster, E Marelise W Eekhoff, Teun J de Vries

Förderung

  • Friends of Dutch FOP foundation

Zitieren

APA

Schoenmaker, T., Zwaak, J., Loos, B. G., Volckmann, R., Koster, J., Eekhoff, E. M. W., & de Vries, T. J. (2023). Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076822

Vancouver

Schoenmaker T, Zwaak J, Loos BG, Volckmann R, Koster J, Eekhoff EMW, et al. Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076822

BibTeX
@article{Schoenmaker2023,
  author = {Schoenmaker, Ton and Zwaak, Joy and Loos, Bruno G and Volckmann, Richard and Koster, Jan and Eekhoff, E Marelise W and de Vries, Teun J},
  title = {Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076822}
}
Kostenlos starten →